Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.93
$81.97
▼
$132.02
$185.89B0.5411.10 million shs8.64 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$144.49
-2.2%
$146.16
$92.11
▼
$156.92
$356.20B0.1310.54 million shs8.61 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+0.57%+1.19%+8.56%+58.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.33
-1.1%
$103.93
$81.97
▼
$132.02
$185.89B0.5411.10 million shs8.64 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$144.49
-2.2%
$146.16
$92.11
▼
$156.92
$356.20B0.1310.54 million shs8.61 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+0.57%+1.19%+8.56%+58.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.3210.24% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.59
Moderate Buy$155.747.79% Upside

Current Analyst Ratings Breakdown

Latest ABT and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/3/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Initiated CoverageStrong-Buy
11/3/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
DowngradeBuy ➝ Hold$153.00
11/2/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Boost Price TargetHold$125.00 ➝ $140.00
11/2/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Boost Price TargetNeutral$145.00 ➝ $155.00
10/30/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Boost Price TargetOverweight$165.00 ➝ $175.00
10/30/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Lower Price TargetSector Perform$145.00 ➝ $140.00
10/30/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Boost Price TargetBuy$170.00 ➝ $171.00
10/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeBuy ➝ Hold
10/26/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Boost Price TargetOverweight$150.00 ➝ $180.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$125.00 ➝ $122.00
10/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetOutperform$130.00 ➝ $125.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$48.23B3.85$6.92 per share15.52$30.35 per share3.54
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B5.48$11.17 per share12.94$21.22 per share6.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6840.0518.131.909.75%18.04%9.09%1/28/2027 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$0.97148.9615.916.773.64%16.73%5.88%2/2/2027 (Estimated)

Latest ABT and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.09$2.49+$0.40$2.04$17.33 billion$18.09 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.35%+10.39%94.03%54 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.402.35%+5.75%350.52%14 Years

Latest ABT and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.45
1.00
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.11
1.35
1.14

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.46 billionOptionable

Recent News About These Companies

Merck & Co., Inc. $MRK Position Lifted by Bessemer Group Inc.
Danske Bank A S Sells 247,694 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stock: Aberdeen Group plc Decreases Stake
What Could Merck (MRK) Gain From Two Positive EU CHMP Opinions?
What Will Decide Merck Stock Over The Next Six Months?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$107.33 -1.19 (-1.10%)
Closing price 03:59 PM Eastern
Extended Trading
$108.08 +0.75 (+0.70%)
As of 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$144.49 -3.27 (-2.22%)
Closing price 03:59 PM Eastern
Extended Trading
$145.67 +1.18 (+0.82%)
As of 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.